BiotechTube
Home/KAHR Medical/Dr. Eli Cohen
DE

Dr. Eli Cohen

CEO

KAHR Medical

Therapeutic Areas

Genetic DisordersOncology

KAHR Medical Pipeline

DrugIndicationPhase
KHR‑001Duchenne Muscular DystrophyPreclinical
KHR‑002Cystic FibrosisPreclinical
KHR‑003Solid Tumor Immuno‑OncologyPreclinical

Leadership Team at KAHR Medical

PY
Prof. Yael Ben‑Ari
CSO
DL
David Levi
COO
View full KAHR Medical profile